国新健康收盘上涨2.62%，最新市净率7.74，总市值107.55亿元

Core Viewpoint - Guoxin Health's stock closed at 10.96 yuan, up 2.62%, with a latest price-to-book ratio of 7.74 and a total market capitalization of 10.755 billion yuan [1] Company Summary - Guoxin Health's main business areas are concentrated in digital medical insurance, digital healthcare, digital pharmaceuticals, and health services [1] - The company's primary products and services include drug and medical device bidding agency services, digital medical insurance, digital pharmaceuticals, and digital healthcare [1] - The "Four Libraries and Twenty-Four Systems" knowledge system of the company is recognized in the industry as the "Four Libraries Encyclopedia" [1] Financial Performance - For the third quarter of 2024, Guoxin Health reported operating revenue of 200 million yuan, a year-on-year increase of 24.40% [1] - The net profit for the same period was -30,946,674.76 yuan, representing a year-on-year decline of 71.49% [1] - The sales gross margin stood at 3.42% [1] Industry Comparison - Guoxin Health's price-to-earnings (P/E) ratio (TTM) is -4903.65, and the static P/E ratio is -134.79, with a price-to-book ratio of 7.74 [2] - The industry average P/E (TTM) is 119.51, and the industry median is 76.28 [2] - The total market capitalization of Guoxin Health is 10.755 billion yuan, compared to the industry average of 119.46 billion yuan [2]